DIG
QNRX

Dauntless Investment Group’s Quoin Pharmaceuticals QNRX Stock Holding History

Dauntless Investment Group’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
214,987
+18,395
+9% +$99.2K 0.82% 25
2026
Q1 		$1.3M Buy
+196,592
New +$1.78M 0.86% 17

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Dauntless Investment Group's QNRX Position: Q2 2026 in Review

Dauntless Investment Group increased its Quoin Pharmaceuticals (QNRX) stake by 9.4% in Q2 2026, buying an estimated $99.2K and bringing the position to 214,987 shares worth $1.04M. The position accounts for 0.82% of the portfolio, ranked #25.

Dauntless Investment Group first reported a position in QNRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.3M in Q1 2026. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Dauntless Investment Group held 214,987 shares of Quoin Pharmaceuticals worth $1.04M as of Q2 2026.
  • Dauntless Investment Group bought 18,395 Quoin Pharmaceuticals shares in Q2 2026, an estimated $99.2K.
  • Quoin Pharmaceuticals made up 0.82% of Dauntless Investment Group's portfolio in Q2 2026, its #25 holding.
  • Dauntless Investment Group first reported a position in Quoin Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Dauntless Investment Group's Quoin Pharmaceuticals position peaked at $1.3M in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.